Judah Folkman's contribution to the inhibition of angiogenesis.
Bielenberg
Diane R
DR
Department of Surgery, Children's Hospital, Boston, MA 02115, USA. diane.bielenberg@childrens.harvard.edu
D'Amore
Patricia A
PA
D000486:Allergy and Immunology / Q000266:history; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D003510:Cyclohexanes / Q000627:therapeutic use; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008495:Medical Oncology / Q000266:history; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology; D009389:Neovascularization, Pathologic; D000077609:O-(Chloroacetylcarbamoyl)fumagillol; D012717:Sesquiterpenes / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D003510:Cyclohexanes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D012717:Sesquiterpenes; D013792:Thalidomide; D000077609:O-(Chloroacetylcarbamoyl)fumagillol